Dispersing tablet for treating diseases of respiratory systems and method for preparing dispersing tablet

A respiratory system disease, dispersion technology, applied in the direction of respiratory system disease, dispersion liquid delivery, organic chemical methods, etc., can solve the problems of poor compressibility, easy sticking, poor solubility of erdosteine, etc., to improve solubility, prevent Effects of sticking punch, improving stability and dissolution rate

Active Publication Date: 2016-12-07
SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD
View PDF14 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0021] The object of the present invention is to provide a new pharmaceutical composition preparation (especially dispersible tablet) for the treatment of respiratory diseases and its preparation method, and provide...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dispersing tablet for treating diseases of respiratory systems and method for preparing dispersing tablet
  • Dispersing tablet for treating diseases of respiratory systems and method for preparing dispersing tablet
  • Dispersing tablet for treating diseases of respiratory systems and method for preparing dispersing tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Embodiment 1: the preparation of erdosteine ​​hydrate

[0061] (1) Get erdosteine ​​crude product 100g, be dissolved in the temperature that 500ml acetone and 200ml ethanol form after grinding and sieving is in the mixed solution of 30 ℃, obtains erdosteine ​​solution;

[0062] (2) add 0.05g of activated carbon for decolorization for 25 minutes, and filter;

[0063] (3) Under the condition of a stirring rate of 23rmp, add 3 times the volume of the erdosteine ​​solution with normal saline at a temperature of -10°C dropwise at a constant speed, and the dropwise addition is completed within 1 hour;

[0064] (4) After the dropwise addition was completed, the temperature was lowered to -10°C and the stirring was continued for 1 h at a stirring rate of 12 rpm, and white crystals were precipitated after standing for 4 h, and filtered;

[0065] (5) Washing successively with distilled water and ethyl acetate, followed by vacuum drying to obtain 98.75 g of erdosteine ​​hydrate c...

Embodiment 2

[0073] Embodiment 2: the preparation of erdosteine ​​hydrate

[0074] (1) Get erdosteine ​​crude product 100g, be dissolved in the temperature that 500ml acetone and 100ml ethanol form after grinding and sieving is in the mixed solution of 25 ℃, obtains erdosteine ​​solution;

[0075] (2) Add 0.1 g of activated carbon for decolorization for 20 minutes, and filter;

[0076] (3) Under the condition of a stirring rate of 20rmp, add 4 times the volume of erdosteine ​​solution with physiological saline at a temperature of 5°C dropwise at a constant speed, and the dropwise addition is completed within 1.5 hours;

[0077] (4) After the dropwise addition was completed, the temperature was lowered to 5° C. and the stirring was continued for 2 h at a stirring rate of 10 rpm, and white crystals were precipitated after standing for 5 h, and filtered;

[0078] (5) Washing with distilled water and ethyl acetate successively, followed by vacuum drying to obtain 98.52 g of erdosteine ​​hydra...

Embodiment 3

[0084] Embodiment 3: the preparation of erdosteine ​​hydrate

[0085] (1) Get erdosteine ​​crude product 100g, be dissolved in the temperature that 500ml acetone and 300ml ethanol form after grinding and sieving is in the mixed solution of 35 ℃, obtains erdosteine ​​solution;

[0086] (2) add 0.02g of activated carbon for decolorization for 30 minutes, and filter;

[0087] (3) Under the condition of a stirring rate of 25rmp, add 2 times the volume of erdosteine ​​solution with normal saline at a temperature of -15°C dropwise at a constant speed, and the dropwise addition is completed within 0.5h;

[0088] (4) After the dropwise addition, cool down to -15°C and continue to stir for 0.5h at a stirring rate of 15rmp, let stand for 3h to precipitate white crystals, and filter;

[0089] (5) Washing successively with distilled water and ethyl acetate, followed by vacuum drying to obtain 98.67 g of erdosteine ​​hydrate crystals.

[0090]Measured by powder X-ray diffraction method, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an erdosteine dispersing tablet for treating diseases of respiratory systems and a method for preparing the dispersing tablets. The erdosteine dispersing tablet comprises erdosteine, hydroxy propyl celluloses, sodium carboxymethyl starch, polyethylene glycol 4000-6000, microcrystalline celluloses 102, crospovidone, magnesium stearate and povidone K30. The erdosteine is erdosteine monohydrate, a molecular formula of the erdosteine is C8H11NO4S2.H2O, and characteristic diffraction peaks are displayed at 3.323, 8.484, 12.661, 21.823, 30.645, 31.161, 33.209, 36.161 and 38.935 positions of X-ray powder diffraction spectra expressed at diffraction angles of 2 theta+/-0.2 degrees. As discovered in tests, the erdosteine dispersing tablet and the method have the advantages that the erdosteine dispersing tablet is good in stability and high in bioavailability, and problems of poor solubility and compressibility, sticking easiness in production procedures and the like of erdosteine dispersing tablets in the prior art can be solved.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to a dispersible tablet for treating respiratory diseases and a preparation method thereof, more specifically, to an erdosteine ​​dispersible tablet and a preparation method thereof. Background technique [0002] Phlegm is the product of respiratory inflammation, which can irritate the respiratory mucosa, cause cough and asthma, and aggravate infection. When patients with acute and chronic bronchitis or chronic lung disease have respiratory failure, if the patient's sputum is too viscous or forms sputum plugs, it can block the airway and cause suffocation. Therefore, it is of great significance to use mucus sputum regulators to dissolve mucus sputum, make it thinner, lower its viscosity, accelerate the movement of mucous membranes and cilia in the respiratory tract, and improve the transport function. [0003] The currently marketed mucus regulators, such as bromhexine, sod...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/381A61K47/38C07D333/36A61P11/00A61P11/10
CPCA61K9/0095A61K9/2059A61K31/381C07B2200/13C07D333/36
Inventor 于德峰刘庆利孟凡磊
Owner SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap